Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068446009> ?p ?o ?g. }
- W2068446009 endingPage "684" @default.
- W2068446009 startingPage "678" @default.
- W2068446009 abstract "Purpose We previously reported the advantages of 18F-fluorodeoxyglucose–positron emission tomography (PET) fused with CT for radiotherapy planning over CT alone in head and neck carcinoma (HNC). The purpose of this study was to evaluate clinical outcomes and the predictive value of PET for patients receiving PET/CT-guided definitive radiotherapy with or without chemotherapy. Methods and Materials From December 2002 to August 2006, 42 patients received PET/CT imaging as part of staging and radiotherapy planning. Clinical outcomes including locoregional recurrence, distant metastasis, death, and treatment-related toxicities were collected retrospectively and analyzed for disease-free and overall survival and cumulative incidence of recurrence. Results Median follow-up from initiation of treatment was 32 months. Overall survival and disease-free survival were 82.8% and 71.0%, respectively, at 2 years, and 74.1% and 66.9% at 3 years. Of the 42 patients, seven recurrences were identified (three LR, one DM, three both LR and DM). Mean time to recurrence was 9.4 months. Cumulative risk of recurrence was 18.7%. The maximum standard uptake volume (SUV) of primary tumor, adenopathy, or both on PET did not correlate with recurrence, with mean values of 12.0 for treatment failures vs. 11.7 for all patients. Toxicities identified in those patients receiving intensity modulated radiation therapy were also evaluated. Conclusions A high level of disease control combined with favorable toxicity profiles was achieved in a cohort of HNC patients receiving PET/CT fusion guided radiotherapy plus/minus chemotherapy. Maximum SUV of primary tumor and/or adenopathy was not predictive of risk of disease recurrence. We previously reported the advantages of 18F-fluorodeoxyglucose–positron emission tomography (PET) fused with CT for radiotherapy planning over CT alone in head and neck carcinoma (HNC). The purpose of this study was to evaluate clinical outcomes and the predictive value of PET for patients receiving PET/CT-guided definitive radiotherapy with or without chemotherapy. From December 2002 to August 2006, 42 patients received PET/CT imaging as part of staging and radiotherapy planning. Clinical outcomes including locoregional recurrence, distant metastasis, death, and treatment-related toxicities were collected retrospectively and analyzed for disease-free and overall survival and cumulative incidence of recurrence. Median follow-up from initiation of treatment was 32 months. Overall survival and disease-free survival were 82.8% and 71.0%, respectively, at 2 years, and 74.1% and 66.9% at 3 years. Of the 42 patients, seven recurrences were identified (three LR, one DM, three both LR and DM). Mean time to recurrence was 9.4 months. Cumulative risk of recurrence was 18.7%. The maximum standard uptake volume (SUV) of primary tumor, adenopathy, or both on PET did not correlate with recurrence, with mean values of 12.0 for treatment failures vs. 11.7 for all patients. Toxicities identified in those patients receiving intensity modulated radiation therapy were also evaluated. A high level of disease control combined with favorable toxicity profiles was achieved in a cohort of HNC patients receiving PET/CT fusion guided radiotherapy plus/minus chemotherapy. Maximum SUV of primary tumor and/or adenopathy was not predictive of risk of disease recurrence." @default.
- W2068446009 created "2016-06-24" @default.
- W2068446009 creator A5003515749 @default.
- W2068446009 creator A5015801829 @default.
- W2068446009 creator A5031303654 @default.
- W2068446009 creator A5034765402 @default.
- W2068446009 creator A5037190803 @default.
- W2068446009 creator A5046522371 @default.
- W2068446009 creator A5047292138 @default.
- W2068446009 creator A5082969884 @default.
- W2068446009 creator A5091775203 @default.
- W2068446009 date "2008-03-01" @default.
- W2068446009 modified "2023-09-25" @default.
- W2068446009 title "Clinical Outcomes of Patients Receiving Integrated PET/CT-Guided Radiotherapy for Head and Neck Carcinoma" @default.
- W2068446009 cites W1865253518 @default.
- W2068446009 cites W1965855929 @default.
- W2068446009 cites W1975501107 @default.
- W2068446009 cites W1978144347 @default.
- W2068446009 cites W1982975352 @default.
- W2068446009 cites W1994998364 @default.
- W2068446009 cites W2001030537 @default.
- W2068446009 cites W2004575509 @default.
- W2068446009 cites W2011209075 @default.
- W2068446009 cites W2012539654 @default.
- W2068446009 cites W2013408153 @default.
- W2068446009 cites W2016866011 @default.
- W2068446009 cites W2017352422 @default.
- W2068446009 cites W2021461364 @default.
- W2068446009 cites W2029657201 @default.
- W2068446009 cites W2041898066 @default.
- W2068446009 cites W2044136498 @default.
- W2068446009 cites W2049719618 @default.
- W2068446009 cites W2056284562 @default.
- W2068446009 cites W2059790467 @default.
- W2068446009 cites W2070982653 @default.
- W2068446009 cites W2072143869 @default.
- W2068446009 cites W2078682667 @default.
- W2068446009 cites W2093474403 @default.
- W2068446009 cites W2111273332 @default.
- W2068446009 cites W2113092282 @default.
- W2068446009 cites W2115674295 @default.
- W2068446009 cites W2119062809 @default.
- W2068446009 cites W2134514924 @default.
- W2068446009 cites W2136250561 @default.
- W2068446009 cites W2136770345 @default.
- W2068446009 cites W2138502548 @default.
- W2068446009 cites W2139389882 @default.
- W2068446009 cites W2151415400 @default.
- W2068446009 cites W2158594928 @default.
- W2068446009 cites W2160433948 @default.
- W2068446009 cites W2168081008 @default.
- W2068446009 cites W2169234727 @default.
- W2068446009 cites W2170253607 @default.
- W2068446009 cites W4211035194 @default.
- W2068446009 doi "https://doi.org/10.1016/j.ijrobp.2007.10.044" @default.
- W2068446009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18262086" @default.
- W2068446009 hasPublicationYear "2008" @default.
- W2068446009 type Work @default.
- W2068446009 sameAs 2068446009 @default.
- W2068446009 citedByCount "88" @default.
- W2068446009 countsByYear W20684460092012 @default.
- W2068446009 countsByYear W20684460092013 @default.
- W2068446009 countsByYear W20684460092014 @default.
- W2068446009 countsByYear W20684460092015 @default.
- W2068446009 countsByYear W20684460092016 @default.
- W2068446009 countsByYear W20684460092017 @default.
- W2068446009 countsByYear W20684460092018 @default.
- W2068446009 countsByYear W20684460092019 @default.
- W2068446009 countsByYear W20684460092020 @default.
- W2068446009 countsByYear W20684460092021 @default.
- W2068446009 countsByYear W20684460092023 @default.
- W2068446009 crossrefType "journal-article" @default.
- W2068446009 hasAuthorship W2068446009A5003515749 @default.
- W2068446009 hasAuthorship W2068446009A5015801829 @default.
- W2068446009 hasAuthorship W2068446009A5031303654 @default.
- W2068446009 hasAuthorship W2068446009A5034765402 @default.
- W2068446009 hasAuthorship W2068446009A5037190803 @default.
- W2068446009 hasAuthorship W2068446009A5046522371 @default.
- W2068446009 hasAuthorship W2068446009A5047292138 @default.
- W2068446009 hasAuthorship W2068446009A5082969884 @default.
- W2068446009 hasAuthorship W2068446009A5091775203 @default.
- W2068446009 hasConcept C120665830 @default.
- W2068446009 hasConcept C121332964 @default.
- W2068446009 hasConcept C121608353 @default.
- W2068446009 hasConcept C126322002 @default.
- W2068446009 hasConcept C126838900 @default.
- W2068446009 hasConcept C127077266 @default.
- W2068446009 hasConcept C146357865 @default.
- W2068446009 hasConcept C151730666 @default.
- W2068446009 hasConcept C167135981 @default.
- W2068446009 hasConcept C199374082 @default.
- W2068446009 hasConcept C201645570 @default.
- W2068446009 hasConcept C2775842073 @default.
- W2068446009 hasConcept C2776530083 @default.
- W2068446009 hasConcept C2776694085 @default.
- W2068446009 hasConcept C2779013556 @default.
- W2068446009 hasConcept C2780283643 @default.
- W2068446009 hasConcept C2989005 @default.